Analysts’ Updated EPS Estimates for July 23rd (APLS, ARWR, GOOS, HRI, MESO, PHM, SPOT, WMT, ZZZ)

Analysts’ updated eps estimates for Tuesday, July 23rd:

Apellis Pharmaceuticals (NASDAQ:APLS) had its outperform rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $100.00 price target on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $60.00 target price on the stock.

Canada Goose (TSE:GOOS) was downgraded by analysts at Raymond James from an outperform rating to a market perform rating.

Herc (NYSE:HRI) had its neutral rating reiterated by analysts at Robert W. Baird. They currently have a $155.00 target price on the stock.

Mesoblast (NASDAQ:MESO) was upgraded by analysts at Piper Sandler from a neutral rating to an overweight rating. The firm currently has $11.00 price target on the stock, up from their previous price target of $4.00.

PulteGroup (NYSE:PHM) had its neutral rating reiterated by analysts at Wedbush. Wedbush currently has a $115.00 price target on the stock, up from their previous price target of $105.00.

Spotify Technology (NYSE:SPOT) had its price target boosted by Macquarie from $345.00 to $395.00. They currently have an outperform rating on the stock.

Walmart (NYSE:WMT) had its target price increased by Tigress Financial from $75.00 to $86.00. They currently have a buy rating on the stock.

Sleep Country Canada (TSE:ZZZ) was downgraded by analysts at TD Securities from a buy rating to a sell rating. They currently have C$35.00 target price on the stock, up from their previous target price of C$33.00.

Sleep Country Canada (TSE:ZZZ) was downgraded by analysts at Stifel Nicolaus from a buy rating to a hold rating. Stifel Nicolaus currently has C$35.00 price target on the stock, up from their previous price target of C$31.00.

Sleep Country Canada (TSE:ZZZ) was downgraded by analysts at National Bankshares, Inc. from a sector perform rating to a tender rating. National Bankshares, Inc. currently has C$35.00 target price on the stock.

Sleep Country Canada (TSE:ZZZ) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. The firm currently has C$35.00 target price on the stock, up from their previous target price of C$32.00.

Receive News & Ratings for Apellis Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apellis Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.